Optogenetic genome engineering tools enable spatiotemporal control of gene expression and provide new insight into biological function. Here, we report the new version of genetically encoded photoactivatable (PA) Cre recombinase, PA-Cre 3.0. To improve PA-Cre technology, we compare light-dimerization tools and optimize for mammalian expression using a CAG promoter, Magnets, and 2A self-cleaving peptide. To prevent background recombination caused by the high sequence similarity in the dimerization domains, we modify the codons for mouse gene targeting and viral production. Overall, these modifications significantly reduce dark leak activity and improve blue-light induction developing our new version, PA-Cre 3.0. As a resource, we have generated and validated AAV-PA-Cre 3.0 as well as two mouse lines that can conditionally express PA-Cre 3.0. Together these new tools will facilitate further biological and biomedical research.
The ability to manipulate DNA recombination and gene expression in a spatiotemporal specific manner is a powerful technique in genome engineering studies1. Cre recombinase, which is derived from P1 bacteriophage, is the most common recombinase that has been used to catalyze directional DNA recombination between loxP pairs2,3,4,5. While various inducible systems have been developed based on Cre-loxP recombination, the tools often suffer from either low efficiency (such as with the CRY2-CIB1-based system) or have complications such as the necessity for harmful chemical inducers such as tamoxifen or rapamycin6,7,8,9. While our previously reported Magnets-based PA-Cre system improved on many of these shortcomings10, PA-Cre still had a major issue with unintentional recombination in dark conditions prior to light stimulation. In addition, there are currently no in vivo mouse models available for optogenetic-based systems, limiting the scope of applications in biological study.
In this study, we developed an improved version of PA-Cre called PA-Cre 3.0, which is based on the same blue-light-dependent dimerization system, Magnets. We demonstrate the improved efficiency of PA-Cre 3.0 and its applications in vivo using newly generated mouse lines expressing PA-Cre 3.0 conditionally. We believe this improved system and mouse model availability can enhance genetic studies in living systems to address biological hypotheses and unveil the molecular and pathophysiological mechanisms underlying various diseases.
Improvement of PA-Cre system
Previously, we developed the 1st generation of Magnets-based PA-Cre, taking advantage of blue-light-dependent hetero-dimerization system, Magnets10. Although the construct of PA-Cre could be successfully transiently applied in mammalian cells in vitro and mouse livers in vivo using hydrodynamic tail vein (HTV) injection and reporter plasmids, other blue-light-inducible hetero-dimerization systems could be more suitable for developing PA-Cre systems. To address this question, CRY2/CIB1-, iLID/SspB-, and FKF1/GI-based PA-Cre constructs were prepared and tested using luciferase (Luc) and mCherry reporters, and compared to the original Magnets-based PA-Cre9,11,12,13 (Fig. 1a–c and Supplementary Fig. 1a, b). We found that the Magnets-based original PA-Cre had the highest Cre-loxP recombination efficiency with light among these constructs (~75% compared with a positive control, CreERT2, treated with tamoxifen). While the fold induction of Cre-loxP recombination using the CRY2/CIB1-based PA-Cre is the best (43.3×) among the tests, the efficiency of Cre-loxP recombination with light was low (~15%) compared with CreERT2 positive control. The FKF1/GI-based version also demonstrated as low Cre-loxP recombination efficiency with blue light as the CRY2/CIB1-based one (called PA-Cre 2.0)11. On the other hand, the iLID/SspB-based version had much higher leakiness in dark than the others. These results suggest that the original Magnets-based PA-Cre is still promising for further improvement as the unintentional Cre-loxP dark leak recombination is limited (Supplementary Fig. 1a). To assess this dark leakiness issue further, we monitored the Luc activity 24, 48, 72, and 96 h after HEK 293T cells were transfected with the PA-Cre constructs. The CRY2/CIB1-based construct, called PA-Cre 2.0 (ref. 11), was also tested as a benchmark experiment. The Magnets-based PA-Cre showed an accumulating leak over time while the CRY2/CIB1 version demonstrated little to no leakiness (Supplementary Fig. 1c). Such leaky recombination in dark after PA-Cre expression is not acceptable for any in vivo applications as Cre-loxP recombination is irreversible. To address this issue, we looked to improve the Magnets-based PA-Cre system by reducing the background dark activity.
To characterize the original PA-Cre further, we conducted protein expression profiling using western blotting with the overexpression of PA-Cre construct in HEK 293T cells. Interestingly, we found that anti-Cre blotting demonstrated non-cleaved form of PA-Cre proteins at ~75 kDa although the most efficient self-cleaving peptide, P2A, has been utilized for this PA-Cre construct10 (Supplementary Fig. 2a–c). Because non-cleaved PA-Cre proteins might not work properly, we hypothesized that the non-cleaved form could be associated with higher leakiness of Cre-loxP recombination with the original PA-Cre in the dark condition. To answer this hypothesis, we prepared a new PA-Cre construct using F2A, which is known to have lower efficiency of self-cleavage than P2A14. In addition, we substituted proline to glycine in the recognition site in order to disrupt P2A-mediated peptide self-cleavage completely to examine whether this mutation affects the leak activity of PA-Cre in dark (Supplementary Fig. 2a, b). Protein characterization using western blotting revealed that the mutated P2A and F2A constructs had significantly increased non-cleaved proteins at ~75 kDa compared with the original P2A-mediated PA-Cre construct in the dark condition (Supplementary Fig. 2c). The interrupted P2A cleavage and F2A version did in fact increase leakiness of Cre-loxP recombination in dark as confirmed via both Luc assay and mCherry reporter (Supplementary Fig. 2d–f).
Because nMag and pMag show 99% match in their DNA sequences, there is another concern that such a high similarity may increase the possibility of unintentional recombination in the mouse genome when PA-Cre is applied for transgenic mouse generation. To remedy this concern, we modified the codon of nMag together with CreN using DNA synthesis and NheΙ and BamHΙ cloning sites (i.e., Magnets-opti, Supplementary Fig. 3). After this codon modification, the DNA sequence of nMag in Magnets-opti has ~79% similarity with pMag without amino acid substitution (Fig. 2a). In addition, we tested not only the promoter of cytomegalovirus (CMV) but also CAG promoter, which contains the promoter of chicken beta-actin gene15. This is because the CMV promoter may be problematic for further in vivo applications as it has been shown to silence the promoter activity in murine systems in vivo while the CAG promoter has shown stronger activity than CMV without silencing issues16,17. To examine whether promoter choice affects the efficiency of P2A self-cleavage in the PA-Cre constructs, western blotting was conducted to profile each PA-Cre construct. We found the nMag codon-modified PA-Cre (Magnets-opti) had less non-cleaved form than the original ones while the total protein expression of Magnets-opti was also reduced (Fig. 2b). The CAG promoter-mediated Magnets-opti construct showed the best induction of Luc (382×) compared to the other iterations (Fig. 2c and Supplementary Fig. 4a). Next, we examined the IRES version of PA-Cre constructs to express CreN59-nMag-NLS and NLS-pMag-CreC60 separately. We found that the IRES was not useful for improving the PA-Cre system (Fig. 2c). This result was also confirmed using a mCherry reporter (Supplementary Fig. 4b–d), allowing us to develop our new version of PA-Cre construct using CAG promoter and nMag codon-modification called PA-Cre 3.0.
To validate the function of PA-Cre 3.0 in vivo, we induced transient expressions of the CAG promoter-driven Magnets-based constructs, both PA-Cre 3.0 and the original one, using HTV injection into mice. Following the plasmid DNA injection, mouse abdomens were exposed to blue light to induce recombination, following the experimental setup of our previous study in which the Luc reporter plasmids were also used with the PA-Cre construct10. However, the validation of Cre-loxP recombination for targeting a single pair of loxP sites is essential for applying the PA-Cre system in vivo. To address this, we utilized Ai14:Floxed-tdTomato heterozygous reporter mouse line, which can express tdTomato red fluorescent proteins in a Cre-loxP recombination-dependent manner18. The original PA-Cre showed higher leakiness in the dark and ambient light conditions whereas the codon-optimized version PA-Cre 3.0 had no spontaneous Cre-loxP recombination at all in the mouse livers (Fig. 2d and Supplementary Fig. 5). Also, we found that the mice injected with PA-Cre 3.0 showed higher recombination efficiency and tdTomato reporter expressions than the original PA-Cre. These results reveal that PA-Cre 3.0 is applicable for blue-light-dependent Cre-loxP recombination in the single loxP pair target in mouse model in vivo. Also, this result suggests that bioluminescence quantification in live mouse livers using Luc reporter10 might not be as reliable and appropriate as tdTomato fluorescent reporter in individual liver cells in order to detect such leak activity of Cre-loxP recombination in vivo tissues.
The mechanism underlying reduced dark leak with codon optimization
To elucidate the molecular mechanisms by which background leakiness is reduced following codon optimization, we compared mRNA and protein expression levels of Magnets and Magnets-opti (Fig. 3a, b). First, we constructed CAG-Magnets-HA and CAG-Magnets-opti-HA plasmids, which inserted HA-tag into the carboxyl-terminus of PA-Cre, which allowed us to quantify the expression of PA-Cre proteins using HA-tag blotting (Fig. 3a). This was primarily done due to non-specific bands seen on blots from cell lysates probed with Cre antibody (Fig. 2b). First, we compared the effect of CMV and CAG promoters on the protein expressions of Magnets and Magnets-opti in HEK 293T cells. We found that there was no difference in Magnets protein between CMV and CAG promoters while CAG promoter increased Magnets-opti expression (Supplementary Fig. 6a). Next, via qPCR, we found that Magnets-opti mRNA expression was significantly lower (~40–50%) than Magnets (Fig. 3c). We then adjusted the cellular transfection in accordance with Magnets-opti transcript levels using different plasmid DNA amounts of Magnets and loaded same amount of PA-Cre proteins in Magnets (lane 3; Magnets, transfection DNA, 40% plus empty vector, 60%) and Magnets-opti (lane 4; Magnets-opti, transfection DNA, 100%) (Fig. 3d and Supplementary Fig. 6b). There are no significant differences between Magnets 40% and Magnets-opti 100% in cleaved and non-cleaved PA-Cre forms (Fig. 3e, f and Supplementary Fig. 6c–e). However, the dark leak was still significantly higher in Magnets 40 than Magnets-opti 100 (Fig. 3g and Supplementary Fig. 6f). Also, dark leak increases along with protein amount in Magnets (Supplementary Fig. 6f). These results suggest that the primary cause of dark leak in Magnets is from excess expression of mRNA and protein of PA-Cre constructs, inducing significant dark leak.
Development of in vivo mouse applications of PA-Cre 3.0
To apply PA-Cre 3.0 to mammalian primary cells, we transduced this construct into mouse primary neural progenitor cells isolated from Ai14: Floxed-tdTomato heterozygous reporter mouse brains. To express PA-Cre 3.0, we applied adeno-associated virus (AAV) using the neuronal activity-dependent promoter, RAM element, and a chemical-controllable system, Tet-off19 (Fig. 4a). Under blue-light conditions with phorbol 12-myristate 13-acetate (PMA), a PKC activator, or high KCl stimuli as depolarization induction, we observed successful Cre-loxP recombination mediated by AAV-RAM-Tet-off-PA-Cre 3.0 in Ai14 mouse-derived neurons (Supplementary Fig. 7a, b). In addition, we confirmed that doxycycline addition prevented light-dependent Cre-loxP recombination via the Tet-off system in vitro. As additional experiments, we tested a doxycycline-fed condition and light stimulation of mouse brain amygdala, which responds to stress, and confirmed that the Tet-off system was functional in the AAV-based mouse model in vivo (Supplementary Fig. 7c) and is consistent with the in vitro results in the primary neural cells (Supplementary Fig. 7a, b). Furthermore, we applied the AAV-RAM-Tet-off-PA-Cre 3.0 viruses into the mouse brain dorsal raphe nucleus, which also responds stress, together with mCherry reporter viruses, and fibrotic light sources. Under blue-light conditions following AAV infection, we observed Cre-lox recombination in c-fos-positive neurons in the mouse brain region while there was no Cre-loxP recombination observed in mice kept in dark (Fig. 4b, c). These results reveal that AAV-RAM-Tet-off-PA-Cre 3.0 virus is a useful resource applicable for mouse brains in vivo.
To better facilitate in vivo studies, we generated a new mouse line by inserting PA-Cre 3.0 construct in the Rosa26 locus (Rosa26-CAG-Frt-Stop-Frt-PA-Cre 3.0, B4 mouse embryonic stem cell clone, Fig. 5a). This mouse line enables for tissue-specific expression of PA-Cre 3.0, following Flp-Frt recombination. To confirm that this targeting strategy is functional in mice, we isolated mouse embryonic fibroblasts (MEFs) from embryos of PA-Cre 3.0 B4 mouse line crossed with Ai14: Floxed-tdTomato reporter mice. We observed the expression of tdTomato red fluorescent proteins, following Flp lentiviral infection and blue-light exposure, revealing the successful Cre-loxP recombination without unintended leakiness in the dark condition (Fig. 5b). As an infection control, the same lentiviral system expressing yellow fluorescent proteins was tested in the MEFs (Supplementary Fig. 8). In addition, we could observe strong and specific tdTomato expressions in livers of PA-Cre 3.0 B4: Ai14 mice, following HTV injections of CAG promoter-mediated Flp plasmids into the mice (Fig. 5c and Supplementary Fig. 9).
Because mouse breeding takes time for experimental design with multiple allele uses, an all-in-one version containing both PA-Cre 3.0 and a fluorescent protein reporter will be valuable for users. Also, transient expression of PA-Cre 3.0 might be ideal as Cre recombination is transient and irreversible and continuous Cre activity might induce neuronal toxicity20. To accomplish this, we added loxP sites in the front and back of PA-Cre 3.0 construct as a self-deficient option in the Rosa26 locus wherein the PA-Cre 3.0 can be removed by itself, following blue-light stimulation leaving only the mKate2 red fluorescent protein reporter expression (Fig. 6a). The advantage of this targeting design is an all-in-one concept for PA-Cre 3.0 and reporter expressions in the single construct. To validate this system, MEFs were isolated from the all-in-one version of PA-Cre 3.0 mouse line (clone A20) crossed with Rosa26-FLPe line. We confirmed that blue-light illumination could induce mKate2 expression, revealing that illumination induces the successful recombination by PA-Cre 3.0 and there is no spontaneous recombination in dark at all (Fig. 6b, c). The primary cortical neurons isolated from the all-in-one PA-Cre 3.0 A20 mouse line and infected with Flp lentiviruses also showed mKate2 expression with blue-light illumination (Fig. 6d, e). The results demonstrate that the all-in-one PA-Cre 3.0 A20 mouse line is a useful and reliable resource in mouse genetic study.
In this study, we have developed a newly improved photoactivatable Magnets-based Cre recombinase named PA-Cre 3.0. The other photoreceptors-based PA-Cre systems have shown to have disadvantages with dark leakiness as well as low recombination efficiency (Fig. 1b). Our new version, PA-Cre 3.0, has significantly addressed the issues. The results (Fig. 3 and Supplementary Fig. 6) suggest that the molecular mechanism underlying PA-Cre improvement is mainly associated with protein expression level during PA-Cre transcription and translation, but not with P2A-mediated self-cleaving efficiency while the accumulated non-cleaved form might become an additional source of dark leak (Supplementary Fig. 2). Particularly, excess expression of PA-Cre proteins may induce spontaneous nMag–pMag and/or CreN-CreC complementation, resulting in leakiness of Cre-loxP recombination in dark. In the original Magnets-based PA-Cre, which has higher dark leak, the highest protein expression has been accomplished using codon modification10. Therefore, there was no difference in CMV-driven Magnets protein expression from ones driven by a CAG promoter, which could increase Magnets-opti protein (Supplementary Fig. 6a). Interestingly, we found that Magnets-opti, PA-Cre 3.0, has a unique advantage of minimizing the dark leak because dark leak of Magnets-opti (transfection DNA: 100%) was significantly lower than Magnets (transfection DNA: 40%), while there was no significant difference in the protein amount of cleaved and non-cleaved forms between Magnets-opti and Magnets (Fig. 3e–g). In particular, dark leak in Magnets-opti did not increase even while mRNA and protein increased (transfection: 75 and 100%) (Supplementary Fig. 6f). According to a previous report21, codons used in Magnets might affect protein folding of PA-Cre and increase spontaneous nMag–pMag/CreN59-CreC60 associations, which induces dark leak. Our findings demonstrate that codon modification is crucial for developing and optimizing genetically encoded tools.
Considering users’ convenience to optimize the amount of blue light needed for single genomic Cre-lox recombination, we infected PA-Cre 3.0 to MEFs isolated from Ai14: Floxed-tdTomato heterozygous reporter mice. In the previous study, reporter plasmids were used. However, a single copy target of loxP pair would be more appropriate to validate the PA-Cre system. We found that at least 5 min of blue-light stimulation was required for Cre-loxP recombination (Supplementary Fig. 10). In addition, we also repeated the 3 h blue-light stimulation under varying amounts of light intensity and we found 1.5 W and greater induced recombination in MEFs. Also, the result of PA-Cre 3.0 application using AAV8 in mouse brains in vivo (Fig. 4 and Supplementary Fig. 7) suggests that standard in vivo optogenetic illumination protocol22 is applicable for activating PA-Cre 3.0.
For in vivo applications, PA-Cre 3.0 B4 and A20 mouse lines were generated and their germ-line transmission was confirmed. We successfully demonstrated the effectiveness of PA-Cre 3.0 in the isolated primary neural cells and MEFs as well as the livers and AAV-infected mouse brains in vivo (Figs. 4–6). As a valuable resource in the research community, the PA-Cre 3.0 mouse lines and viruses will be useful and shared to facilitate spatiotemporal Cre-loxP recombination for further biological applications.
Plasmid DNA constructs were generated using standard methods with restriction enzymes (New England BioLabs), DNA ligase (MightMix, TaKaRa) and polymerase chain reaction (PCR) with Phusion polymerase (Thermo-Fisher). The transient expression vector pcDNA3.1 (Life Technologies) was used with the CMV promoter, and lentiviral vector LV-SD vector (Addgene, #12105, LV-Cre-SD, no longer available currently) was used as CAG promoter-mediated vector. The CMV promoter-mediated Magnets-based PA-Cre was developed in our previous study10. We synthesized the codon-modified CreN59, nMag and NLS sequences (Integrated DNA Technologies, IDT) and inserted into Nhe I/BamH I sites instead of the original codon sequences without any amino acid substitution. The CRY2/CIB1 vector was kindly gifted from Dr. C. Tucker (Univ. Colorado). To construct the iLID/SspB-based PA-Cre plasmid, the full-length iLID/SspB-based PA-Cre construct was synthesized and inserted Nhe I/Xba I sites of pcDNA3.1 vector. To construct the FKF1/GI vectors, we used pcDNA3-NLS-Gal4DBD-NLOV(H105L)-HA vector and pcDNA3-FLAG-GI-VP16 (ref. 13) as backbone vectors. We cut out the Gal4DBD and inserted NLS-CreN59 into Kpn I/Not I sites of pcDNA3-NLS-Gal4DBD-NLOV(H105L)-HA. We cut out VP16 and inserted CreC60 into Not I/Xba I sites of pcDNA3-FLAG-GI-VP16 vector. To construct the CreERT2 plasmid, we used pCAG-CreERT2 (Addgene, #14797) as a PCR template and inserted CreERT2 sequence into EcoR I/Not I sites of pcDNA 3.1 vector. To construct the P2A mutant and F2A, we used CMV-mediated Magnets-based PA-Cre10 as a backbone vector and inserted the synthesized constructs into BamH I/Xho I sites. To construct the CMV-mediated Magnets- Magnets-opti-based PA-Cre IRES versions, we used CRY2/CIB1-based version, called PA-Cre 2.0 (ref. 11), as a PCR template for IRES sequences and inserted IRES sequence into BamH I/Xho I sites of each vector instead of P2A sequence. To construct the CAG-mediated Magnets, Magnets-IRES, Magnets-opti, and Magnets-opti-IRES vectors, we cut out Magnets, Magnets-IRES, Magnets-opti and Magnets-opti-IRES portions from CMV-Magnets, CMV-Magnets-IRES, CMV-Magnets-opti, and CMV-Magnets-opti-IRES, respectively. And then we inserted each into Nhe I/Xba I sites of LV-SD vector that contains homemade multi cloning sites (MCS), EcoRI-AscI-NheI-PacI-XbaI-XhoI, instead of EcoRI-NLS-Cre-XhoI. To construct the AAV-PA-Cre 3.0 vector, we used pRAM-d2TTA-TRE-MCS-WPRE-pA (Addgene #63931) as a backbone vector. We inserted Magnets-opti version (PA-Cre 3.0) sequence into Nhe I/Asc I sites and deleted the WPRE sequences in order to maintain AAV packaging capacity. To construct the mouse targeting vector, we used STOP-eGFP-ROSA26TV (Addgene, #11739) as a backbone vector. We subcloned CAG promoter_FRT_TKneo-polyA_FRT_loxP_Magnets-opti_WPRE-polyA_loxP_Kozak-NLS-mKate2-STOP sequence and used it as an all-in-one targeting vector (named, #A20, a positive mouse embryonic stem cell clone). We also subcloned CAG promoter_FRT_TKneo-polyA_FRT_Magnets-opti sequence and used it as a targeting vector (named B4). To construct CMV-Magnets-HA, CMV-Magnets-opti-HA, CMV-Magnets-opti-IRES-HA, CAG-Magnets-HA and CAG-Magnets-opti-HA, we synthesized HA-tag; HA, 5′-GCTGGCTCCTACCCATACGATGTTCCAGATTACGCT-3′ and inserted to the carboxyl terminal of each vector, respectively.
Experiments using mice were performed in accordance with the Guidelines for Care and Use of Laboratory Animals as stated by Columbia University IACUC. The Rosa26Ai14/Ai14 mouse (B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J; The Jackson Laboratory, Stock no: 007914) were purchased from the Jackson Laboratory and crossed with C57BL/6 mice to generate Rosa26Ai14/WT. Rosa26Ai14/WT mice were sacrificed for HTV injection at 5–6-week-old and also used for MEFs isolation at E11.5–13.5 and used for neuronal progenitor cells (NPCs) isolation at E12.5. To generate PA-Cre chimeric mice, we established mouse embryonic stem cells (mESCs) lines (A20 and B4) with integration of Magnets-opti into Rosa26 locus. mESC injection into blastocysts for chimeric mouse generation was accomplished at the transgenic animal facility in Columbia University Medical Center. The PA-Cre chimeric mice were crossed with C57BL/6 mice and confirmed the germ-line transmission by genotyping PCR. F1, F2, and F3 generations named Rosa26PA-Cre A20 or PA-Cre B4/WT maintained by crossing with C57BL/6 mice. The Rosa26PA-Cre B4/WT mice were crossed with Rosa26Ai14/Ai14 mice to generate Rosa26PA-CreB4/Ai14. Rosa26PA-CreB4/Ai14 mice used for HTV injection at 5–6-week-old and also sacrificed to isolate the MEF at E11.5–13.5. The Rosa26PA-Cre A20/WT mice were used cortical neuron isolation at P1-4. The Rosa26PA-Cre A20/WT mice were crossed with Rosa26FLPe/FLPe mice (B6.129S4-Gt(ROSA)26Sortm1(FLP1)Dym/RainJ, JAX# 009086) to generate Rosa26PA-Cre A20/FLPe. Rosa26PA-Cre A20/FLPe mice used for MEF isolation at E11.5–14.5.
Human embryonic kidney (HEK) 293T cells (ATCC, #CRL-3216) were cultured in Dulbecco’s Modified Eagle Media (DMEM, Thermo-Fisher) supplemented with 1% GlutaMax I (Thermo-Fisher) and 100 U/ml penicillin and 100 µg/ml streptomycin (P.S., Thermo-Fisher) and 10% fetal bovine serum (FBS, not heat-inactivated, HyClone, Thermo-Fisher). HEK 293T cells were passaged using 0.05% trypsin + 0.03% EDTA solution (Thermo-Fisher). mESCs derived from C57BL/6 and 129SV/EV hybrid mouse (by Columbia Transgenic mouse facility, Chyuan-Sheng Lin) were cultured on Mitomycin C-treated DR4 feeder cells. The cells were maintained DMEM (Thermo-Fisher) supplemented with 20% FBS, nonessential amino acids (NEAA, Thermo-Fisher), 1% GlutaMax I, 1% nucleosides (Millipore-Sigma, ES-008-D), and 2-mercaptoethanol (Sigma-Aldrich). The targeting vector was electroporated into undifferentiated mESCs. Twenty-four hours after electroporation, the medium was replaced by selection medium containing the 50 μg/mL G418 (Clontech) for 7 days to establish the targeting mESC lines. The targeting plasmid integration was confirmed by PCR with following primers: 5′ GGACTAGGGCTGCGTGAGTCTCTGA (forward) and GGCGTTACTATGGGAACATACGTC (reverse). The targeting mESCs were used for chimeric mice generation. MEFs cells were isolated from E11.5 to E13.5 mouse embryos by using 0.25% Trypsin-EDTA (Thermo-Fisher) and DNase solution (Worthington). MEF cells were cultured in DMEM supplemented with 10% FBS, 1% GlutaMax I, and P.S. MEF cells were passaged using 0.25% trypsin + 0.03% EDTA. NPCs were isolated from brains of E12.5 mouse embryos and dissociated with accutase (Thermo-Fisher) and DNase Ι solution (Stem Cell Technologies). NPCs were proliferated with neural induction medium, its supplement, and Advanced DMEM/F12 medium (both from Thermo-Fisher) and then differentiated to neurons by Neurobasal Plus medium (Thermo-Fisher) supplemented with B27 (Thermo-Fisher), BDNF (PeproTech), NT3 (PeproTech), 1% GlutaMax I, and P.S. Cortical neurons were isolated from P1 to P4 mouse by using Papain, Hibernate A, and DNase solution. The cells were harvested on PDL/laminin-coated dish with Neurobasal medium, B27, and 1% FBS. The following day, the medium was changed to Neurobasal medium supplemented with B27, 1% GlutaMax I, HEPES (all, Thermo-Fisher), and P.S. All cells were cultured under normoxia (20% O2, 5% CO2, at 37 °C) using HERAcell CO2/O2 incubator (Thermo-Fisher).
HEK 293T cells were plated at 0.5 × 105 cells/well in 24 well plates (Corning) coated with poly-ornithine (Sigma-Aldrich). The following day, the cells were transfected with cDNAs encoding PA-Cre along with Firefly Luc reporter and Renilla Luc using X-treameGENE9 reagent (Sigma-Aldrich). The standard transfection ratio of PA-Cre:double-flox-inverted-FLuc:HSV-TK-Renilla Luc was as follows: 1:9:0.1. The cells were then exposed to blue light (total 12 h, 20 s light/60 s dark cycle, homemade device13) 36 h after transfection at 37 °C in a CO2 incubator (Thermo-Fisher). In case of tamoxifen-treated Mock or CreERT2, the cells were treated with 1 μM tamoxifen (Sigma-Aldrich) 36 h after transfection. Luc activity levels were assayed right after illumination was terminated using Dual Luciferase assay kit and Veritas 96-well luminometer (Promega) following the manufacturer’s instructions.
HEK 293T cells were plated at 2 × 105 cells/dish in 3.5 cm glass bottom dish (MatTek) coated with poly-ornithine. The following day, the cells were transfected with cDNAs encoding PA-Cre along with Floxed-mCherry reporter using X-treameGENE9 reagent. The standard transfection ratio is PA-Cre and Floxed-mCherry at 1:9 ratio. The cells were then exposed to blue light (total 12 h, 20 s light/60 s dark cycle, homemade device) 36 h after transfection at 37 °C in a CO2 incubator. The cells were imaged with TxRed filters and Nikon NIS using the custom Nikon microscope Ti-E immediately after illumination was completed. The Cre-loxP recombination efficiency were analyzed by ImageJ software (NIH) upon the red fluorescent signals. MEF cells, NPCs, and cortical neurons were also imaged with TxRed filters and Nikon NIS using the custom Nikon microscope Ti-E.
The protein samples were extracted from HEK 293T cells transfected with each plasmid (pcDNA3.1, Cre, CMV-Magnets, CMV-Magnets-F2A, CMV-Magnets-P2A mutant, CMV-Magnets-opti, CAG-Magnets, CAG-Magnets-opti, CMV-Magnets-HA, CMV-Magnets-opti-HA, CMV-Magnets-opti-IRES-HA, CAG-Magnets-HA, and CAG-Magnets-opti-HA) using extraction buffer (50 mM Tris-HCl (pH7.4), 150 mM NaCl, 1% TritonX-100, and 1% protease inhibitor cocktails). Cells were kept in dark and harvested 48 h after transfection. The samples were placed on ice for 30 min to complete permeabilization. Lysate were centrifuged at 14,000 rpm for 10 min at 4 °C to remove cell debris. The supernatant samples were moved to new tubes. An equal volume of 2× sodium dodecyl sulfate (SDS) sample buffer (8M Urea, 40 mM Tris-HCl pH7.4, 2% SDS, 10% 2-mercaptoethanol, and 0.01% bromophenol blue) was added to the lysate samples and boiled for 5 min on heat block (~95 °C). The protein samples were subjected to SDS-polyacrylamide gel electrophoresis using Tris-Glycine-based gels (Bio-Rad) containing 10% Acrylamide-Bis (Fisher Scientific), and then electro-transferred Polyvinylidene difluoride (PVDF) membranes using XCell SureLock® Mini-Cell and XCell™ Blot Module system (Life Technologies). The membranes were blocked with 5% or 10% nonfat milk powder in TBS-T (Tris-based saline solution with Tween, 50 mM Tris-HCl, 150 mM NaCl, and 0.1% Tween) or 1% bovine serum albumin (BSA) in TBS for overnight at 4 °C or 1–4 h at room temperature (RT). Then, the membranes were incubated with following primary antibodies: anti-Cre (Abcam, #ab24608, 1:1000 dilution in TBS-T solution with 5% BSA), anti-HA (Roche, #11867423001, 1:1000 in TBS solution with 1% BSA), and anti-β-tubulin (Sigma-Aldrich, #T5201, 1:8000 dilution in TBS-T solution with 5% BSA or in TBS solution with 1% BSA) for 1 h at RT followed by an incubation of the corresponding secondary antibody (Thermo-Fisher, Pierce, anti-rabbit, #31460; anti-mouse #31430; anti-rat, #31470 1:8000 dilution in TBS-T with 5% nonfat skim milk or in TBS solution with 1% BSA) for 1 h at RT. The protein signals were detected using Pierce ECL western blotting substrate (Thermo-Fisher) by exposing to X-ray films (Thermo-Fisher) in a dark room. The original blots are also available in scanned film images provided in the Supplementary Source Data file.
The RNA samples were extracted from HEK 293T cells transfected with each plasmid (pcDNA3.1, CMV-Magnets-HA, CMV-Magnets-opti-HA, CMV-Magnets-opti-IRES-HA, CAG-Magnets, CAG-Magnets-HA, and CAG-Magnets-opti-HA) using RLT buffer (Qiagen). Cells were kept in dark and harvested 48 h after transfection. The RNA was prepared using RNeasy Mini kit and RNase-Free DNase set (Qiagen). cDNA was synthesized using the SuperScript III First-Strand Synthesis System for RT-PCR (Thermo-Fisher). The cDNA (21 µl) was diluted with DNase-free water (Thermo-Fisher) at a ratio of 1:4 and 1 µl of the samples was used for qPCR analysis. SYBR Advantage qPCR Premix (Clontech/TaKaRa Bio) and StepOnePlus real time PCR systems (Thermo-Fisher) were used for qPCR. The primer sets for detecting the CreC60 and GAPDH transcripts were as follows: CreC60, Forward 5′-GAGATACCTGGCCTGGTCTGG-3′, Reverse 5′-ACATTGGTCCAGCCACCAGC-3′; GAPDH, Forward 5′-GATGACATCAAGAAGGTGGTGA-3′, Reverse 5′-GTCTACATGGCAACTGTGAGGA-3′ (oligo synthesis, IDT). The CT value of each sample at 50% of the amplification curve was used and GAPDH was used to normalize the expression of CreC60.
Hydrodynamic tail vein injection
We used 5–6-week-old Rosa26Ai14/WT mouse or Rosa26PA-Cre B4/Ai14 mouse. The abdominal surface furs of mice were removed using hand trimer. The fur-removed mice were rested for at least 24 h in a cage, and intraperitoneally injected with cDNAs encoding CAG-Magnets, CAG-Magnets-opti, Cre, or pCAG-Flpe (Addgene, #13787) using TransIT®-EE Delivery Solution (Mirus Bio LLC), respectively, according to the manufacturer’s protocol. The amount of injected DNA was 10 μg per mouse. The volume of delivery solution was 0.1 mL per mouse weight (g). After the hydrodynamic injection of DNA, the mice were kept in the dark for 8 or 32 h and then illuminated with a LED source (470 ± 20 nm; 200 W/m2, CCS) for 16 h in a cage. After illumination, the mice were kept in the dark to recovery for 24 h. As with ambient light illumination, the mice were kept under a standard white fluorescent light (0.05 W/m2) for 48 or 72 h. The mice were sacrificed using standard procedure approved in our animal protocol and their livers were immediately harvested for fluorescent imaging with fluorescent stereoscope (Zeiss).
In vitro lentiviral infection
To produce the lentivirus, the LV-SD-Magnets, LV-SD-Magnets-opti, LV-SD-Flpe or LV-SD-YFP vector were transfected together with pCMV-dr8.2 dvpr (Addgene #8455) and pCMV-VSV-G (Addgene #8454) into HEK 293T cells. Forty-eight and seventy-two hours after transfection, the supernatants of culture media were collected and concentrated by using Lenti-X concentrator (TaKaRa), following the manufacture’s instruction. The lentiviral infection to MEF and cortical neuron cells were conducted once or twice as shown in the experimental procedures of figures. Blue-light illumination was started 24 h after last infection. The following day or 2 days after the illumination, reporter expression was imaged and analyzed using the custom Nikon microscope Ti-E.
Adeno-associated viral infection
Adeno-associated viral (AAV) production was accomplished at the virology core facility in Columbia University. The 9.5 × 1010 vg adenovirus infected into neurons derived from NPCs in 3.5 cm film-bottom dish (Matsunami). One week after the infection, 1 μM PMA (12-myristate-13-acetate, Sigma-Aldrich) was treated with 24 h blue-light illumination. Following the PMA treatment, 67 mM KCl (Sigma-Aldrich) was treated with 6 h blue-light illumination (470 ± 20 nm, 1 W/m2, continuous, CCS). The fluorescence images were obtained at the following day after the blue-light illumination using the above custom Nikon microscope. Male C57BL/6 J mice (age: 8–10 weeks old) were injected with 200 nl 50:50 mixture of AAV8-hSyn-DIO-mCherry (titer = 1.3 × 1013, Addgene) and AAV8-RAM-PA-Cre (titer = 4.6 × 1012 vg/ml, Columbia Vector core) into the target regions of mouse brains. Fabricated fiber optics were implanted 200 µm above injection sites22. Following surgery, the AAV8-infected mice were either placed on doxycycline diet (200 mg/kg, Bioserv) or regular diet and given 3 weeks to allow expression of virally delivered proteins. Blue light (470 nm, 5–7 mW) was delivered through a fiber optic at a pulse rate of “2 s on/1 s off”. Three weeks later, the mice were restrained using the standard manual restraint method23. Specifically, the mice were placed headfirst in a ventilated 50 ml conical tube and confined with a plunger to restrict movement for 1 h. The restraint procedure was used to induce neuronal activation in the target brain area, resulting in increased c-fos+ neurons. The whole body of mice were perfused and fixed wit 4% paraformaldehyde for 1 h immediately after end of restraint, and then the brains were harvested for cryosection. Amygdala sections were stained with primary antibodies for c-fos (polyclonal anti-rabbit, Synaptic Systems, Cat#226003) and mCherry (monoclonal anti-rat, 1:500, Invitrogen Cat#16D7) and secondary antibodies (goat anti-rabbit Alexa 488 Cat#A11008, goat anti-rat Alexa 568, Invitrogen Cat#A11077) as well as nuclear stain Draq5 (5 µM, Thermo-Fisher Cat#62254). Dorsal raphe sections were processed as described previously22. Immunofluorescent images were collected on Leica DMi8 confocal microscope.
The statistical significance (P value) was used to compare samples with/without light exposure was determined using a F-test and a two-tailed Student’s t test (Prism 7–8, GraphPad, or Excel, Microsoft). The statistical significance of the comparison of multiple samples was computed using Ordinary one-way ANOVA with multiple comparisons (Prism 7–8). The exact p value is provided in the Supplementary Source Data file.
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Akopian, A. & Marshall Stark, W. Site-specific DNA recombinases as instruments for genomic surgery. Adv. Genet. 55, 1–23 (2005).
Sternberg, N. Bacteriophage P1 site-specific recombination. III. Strand exchange during recombination at lox sites. J. Mol. Biol. 150, 603–608 (1981).
McLellan, M. A., Rosenthal, N. A. & Pinto, A. R. Cre-loxP-mediated recombination: general principles and experimental considerations. Curr. Protoc. Mouse Biol. 7, 1–12 (2017).
Van Duyne, G. D. Cre Recombinase. Microbiol. Spectr. 3, MDNA3–2014 (2015).
Gierut, J. J., Jacks, T. E. & Haigis, K. M. Strategies to achieve conditional gene mutation in mice. Cold Spring Harb. Protoc. 2014, 339–349 (2014).
Taslimi, A. et al. Optimized second-generation CRY2-CIB dimerizers and photoactivatable Cre recombinase. Nat. Chem. Biol. 12, 425–430 (2016).
Laplante, M. & Sabatini, D. M. mTOR signaling in growth control and disease. Cell 149, 274–293 (2012).
Chen, D., Wu, C. F., Shi, B. & Xu, Y. M. Tamoxifen and toremifene cause impairment of learning and memory function in mice. Pharmacol. Biochem. Behav. 71, 269–276 (2002).
Guntas, G. et al. Engineering an improved light-induced dimer (iLID) for controlling the localization and activity of signaling proteins. Proc. Natl Acad. Sci. USA 112, 112–117 (2015).
Kawano, F., Okazaki, R., Yazawa, M. & Sato, M. A photoactivatable Cre-loxP recombination system for optogenetic genome engineering. Nat. Chem. Biol. 12, 1059–1064 (2016).
Meador, K. et al. Achieving tight control of a photoactivatable Cre recombinase gene switch: new design strategies and functional characterization in mammalian cells and rodent. Nucleic Acids Res. 47, e97 (2019).
Yazawa, M., Sadaghiani, A. M., Hsueh, B. & Dolmetsch, R. E. Induction of protein–protein interactions in live cells using light. Nat. Biotechnol. 27, 941–945 (2009).
Quejada, J. R. et al. Optimized light-inducible transcription in mammalian cells using Flavin Kelch-repeat F-box1/GIGANTEA and CRY2/CIB1. Nucleic Acids Res. 45, e172 (2017).
Kim, J. H. et al. High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice. PloS ONE 6, e18556 (2011).
Miyazaki, J. et al. Expression vector system based on the chicken beta-actin promoter directs efficient production of interleukin-5. Gene 79, 269–277 (1989).
Mehta, A. K., Majumdar, S. S., Alam, P., Gulati, N. & Brahmachari, V. Epigenetic regulation of cytomegalovirus major immediate-early promoter activity in transgenic mice. Gene 428, 20–24 (2009).
Chen, C. M., Krohn, J., Bhattacharya, S. & Davies, B. A comparison of exogenous promoter activity at the ROSA26 locus using a PhiiC31 integrase mediated cassette exchange approach in mouse ES cells. PloS ONE 6, e23376 (2011).
Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133–140 (2010).
Sorensen, A. T. et al. A robust activity marking system for exploring active neuronal ensembles. eLife 5, e13918 (2016).
Pfeifer, A., Brandon, E. P., Kootstra, N., Gage, F. H. & Verma, I. M. Delivery of the Cre recombinase by a self-deleting lentiviral vector: efficient gene targeting in vivo. Proc. Natl Acad. Sci. USA 98, 11450–11455 (2001).
Kimchi-Sarfaty, C. et al. A “silent” polymorphism in the MDR1 gene changes substrate specificity. Science 315, 525–528 (2007).
Garcia-Garcia, A. L. et al. Serotonin inputs to the dorsal BNST modulate anxiety in a 5-HT1A receptor-dependent manner. Mol. Psychiatry 23, 1990–1997 (2018).
Machholz, E. et al. Manual restraint and common compound administration routes in mice and rats. J. Vis. Exp. 67, 2771 (2012).
We thank Chandra Tucker (University of Colorado, Aurora) for sharing her PA-Cre 2.0 construct. This study is supported by CREST (Core Research for Evolutionary Science and Technology) Program (to M.S. and M.Y.) and Columbia Stem Cell Initiative (to M.Y.).
The authors declare no competing interests.
Peer review information Nature Communications thanks Won Do Heo and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Morikawa, K., Furuhashi, K., de Sena-Tomas, C. et al. Photoactivatable Cre recombinase 3.0 for in vivo mouse applications. Nat Commun 11, 2141 (2020). https://doi.org/10.1038/s41467-020-16030-0